130 related articles for article (PubMed ID: 32196727)
21. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of two commercial test kits for detection of occult blood in feces of dogs.
Gilson SD; Parker BB; Twedt DC
Am J Vet Res; 1990 Sep; 51(9):1385-7. PubMed ID: 2396786
[TBL] [Abstract][Full Text] [Related]
23. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
Koïvogui A; Mab GL; Benamouzig R
Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.
Brenner H; Hoffmeister M; Birkner B; Stock C
Am J Gastroenterol; 2014 Mar; 109(3):427-35. PubMed ID: 24343548
[TBL] [Abstract][Full Text] [Related]
25. Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.
Hunter JP; Saratzis A; Froggatt P; Harmston C
Colorectal Dis; 2012 Sep; 14(9):1084-9. PubMed ID: 22122559
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
27. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive screening for colorectal cancer in Asia.
Chiu HM; Chang LC; Hsu WF; Chou CK; Wu MS
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):953-65. PubMed ID: 26651256
[TBL] [Abstract][Full Text] [Related]
29. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.
Rabeneck L; Zwaal C; Goodman JH; Mai V; Zamkanei M
Clin Biochem; 2008 Nov; 41(16-17):1289-305. PubMed ID: 18796300
[TBL] [Abstract][Full Text] [Related]
30. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program.
Sultanian R; Du L; Moysey B; Morse A; Veldhuyzen van Zanten S; Montano-Loza AJ
J Can Assoc Gastroenterol; 2020 Aug; 3(4):177-184. PubMed ID: 32671327
[TBL] [Abstract][Full Text] [Related]
32. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S
J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730
[TBL] [Abstract][Full Text] [Related]
33. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
34. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
35. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.
Sinatra MA; St John DJ; Young GP
Clin Chem; 1999 Jan; 45(1):123-6. PubMed ID: 9895348
[TBL] [Abstract][Full Text] [Related]
36. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
[TBL] [Abstract][Full Text] [Related]
37. Rectally obtained fecal samples can be used for fecal occult blood testing in dogs, and fecal immunochemical tests do not detect canine or feline blood.
Chappell K; Van Vertloo L; Viall A; Scaccianoce J; LeVine DN
Am J Vet Res; 2024 Jan; ():1-7. PubMed ID: 38262140
[TBL] [Abstract][Full Text] [Related]
38. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
[TBL] [Abstract][Full Text] [Related]
39. Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening.
Kaalby L; Al-Najami I; Deding U; Berg-Beckhoff G; Steele RJC; Kobaek-Larsen M; Shaukat A; Rasmussen M; Baatrup G
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008412
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical faecal occult blood tests have superior stability and analytical performance characteristics over guaiac-based tests in a controlled in vitro study.
Lee CS; O'Gorman P; Walsh P; Qasim A; McNamara D; O'Morain CA; Boran GP
J Clin Pathol; 2011 Jun; 64(6):524-8. PubMed ID: 21512110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
